Evaluating NASDAQ:DXCM for Growth Investment Opportunities.

In this article we will dive into DEXCOM INC (NASDAQ:DXCM) as a possible candidate for growth investing. Investors should always do their own research, but we noticed DEXCOM INC showing up in our Louis Navellier growth screen, which makes it worth to investigate a bit more.

Looking into the growth metrics of DEXCOM INC

• DEXCOM INC has a healthy Return on Equity(ROE) of 16.62%. This demonstrates the company's efficient utilization of capital and indicates its commitment to driving profitability.
• DEXCOM INC has consistently exceeded EPS estimates in the last 4 quarters, demonstrating its ability to outperform market expectations. This trend highlights the company's strong financial performance and its potential for future growth.
• The 1-year revenue growth of DEXCOM INC (21.85%) has been strong, reflecting the company's ability to generate consistent sales growth. This growth suggests the company's ability to meet customer needs and expand its market share.
• DEXCOM INC has achieved 26.69% growth in its revenue over the previous quarter, signaling positive momentum in its financial performance and potential market opportunities.
• With a favorable trend in its operating margin over the past year, DEXCOM INC demonstrates its ability to enhance profitability through efficient operations. This growth reflects the company's focus on optimizing its cost structure.
• DEXCOM INC has shown positive growth in its free cash flow (FCF) over the past year, indicating improved cash generation and financial strength. This growth highlights the company's ability to effectively manage its cash flows and generate surplus funds.
• DEXCOM INC has shown positive momentum in its earnings per share (EPS) on a quarter-to-quarter (Q2Q) basis, with a 78.57% increase. This reflects the company's successful execution of its business strategies and its commitment to delivering improved financial results.
• The average next Quarter EPS Estimate for DEXCOM INC has experienced a 11.02% change in the last 3 months, reflecting evolving expectations by analysts regarding the company's EPS performance.
• In the most recent financial report, DEXCOM INC reported a 78.57% increase in quarterly earnings compared to the previous quarter. This notable growth indicates positive momentum in the company's financials, suggesting an upward trend
• accelerating EPS growth for DEXCOM INC: the current Q2Q growth of 78.57% exceeds the previous year Q2Q growth of 25.84%.

Zooming in on the fundamentals.

Every day ChartMill assigns a Fundamental Rating to every stock. The score ranges from 0 to 10 and is determined by evaluating multiple fundamental indicators and properties.

Overall DXCM gets a fundamental rating of 7 out of 10. We evaluated DXCM against 199 industry peers in the Health Care Equipment & Supplies industry. DXCM scores excellent on profitability, but there are some minor concerns on its financial health. DXCM is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make DXCM suitable for growth investing!

Our latest full fundamental report of DXCM contains the most current fundamental analsysis.

More ideas for growth investing can be found on ChartMill in our Lois Navellier screen.

Keep in mind

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.